HTG Molecular Provides Update on Patent Infringement Claims Against BioSpyder

TUCSON, Ariz. , Aug. 14, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today provided an update regarding its patent infringement claims against BioSpyder Technologies, Inc (BioSpyder).